epilepsy

With U.S. HQ in Dallas, Epiminder Gets FDA Authorization for Implantable Monitor for Epilepsy Patients

by | Apr 23, 2025
"As the first and only implantable continuous EEG monitor approved in the U.S., Minder can provide health care professionals and their patients with more accurate and timely diagnoses, enhanced therapeutic drug monitoring, and can better inform decisions on non-drug treatments like surgery," said Epiminder CEO Rohan Hoare.
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.